AU2575399A - Oxazole derivatives as serotonin-1a receptor agonists - Google Patents

Oxazole derivatives as serotonin-1a receptor agonists

Info

Publication number
AU2575399A
AU2575399A AU25753/99A AU2575399A AU2575399A AU 2575399 A AU2575399 A AU 2575399A AU 25753/99 A AU25753/99 A AU 25753/99A AU 2575399 A AU2575399 A AU 2575399A AU 2575399 A AU2575399 A AU 2575399A
Authority
AU
Australia
Prior art keywords
serotonin
receptor agonists
oxazole derivatives
oxazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25753/99A
Inventor
Lynne Padilla Greenblatt
Michael Gerard Kelly
Frances Christy Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2575399A publication Critical patent/AU2575399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
AU25753/99A 1998-02-03 1999-02-02 Oxazole derivatives as serotonin-1a receptor agonists Abandoned AU2575399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1751798A 1998-02-03 1998-02-03
US09017517 1998-02-03
PCT/US1999/002210 WO1999038864A1 (en) 1998-02-03 1999-02-02 Oxazole derivatives as serotonin-1a receptor agonists

Publications (1)

Publication Number Publication Date
AU2575399A true AU2575399A (en) 1999-08-16

Family

ID=21783033

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25753/99A Abandoned AU2575399A (en) 1998-02-03 1999-02-02 Oxazole derivatives as serotonin-1a receptor agonists

Country Status (6)

Country Link
EP (1) EP1053235A1 (en)
JP (1) JP2002501920A (en)
CN (1) CN1289333A (en)
AU (1) AU2575399A (en)
CA (1) CA2317515A1 (en)
WO (1) WO1999038864A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242448B1 (en) * 1998-12-17 2001-06-05 American Home Products Corporation Trisubstituted-oxazole derivatives as serotonin ligands
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR032641A1 (en) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd RECEIVER SUBTIPE AGONIST 5-HT 1A.
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
AR033485A1 (en) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
CA2594943A1 (en) * 2005-01-19 2006-07-27 Merck & Co., Inc. Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease
GB0516313D0 (en) * 2005-08-08 2005-09-14 Argenta Discovery Ltd Azole derivatives and their uses
US9902711B2 (en) * 2013-12-20 2018-02-27 Laboratorios Del Dr. Esteve S.A. Piperidine compounds having multimodal activity against pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02167280A (en) * 1988-08-15 1990-06-27 Glaxo Group Ltd Lactam derivative
US5162322A (en) * 1991-03-06 1992-11-10 A. H. Robbins Company, Incorporated Method of treating anxiety with 5-[(4-aryl or heteroaryl-1-piperazinyl]alkyl)-2-oxazolidinones

Also Published As

Publication number Publication date
JP2002501920A (en) 2002-01-22
CN1289333A (en) 2001-03-28
WO1999038864A1 (en) 1999-08-05
EP1053235A1 (en) 2000-11-22
CA2317515A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
AU5203999A (en) Beta3-adrenergic receptor agonists
AU1052599A (en) Retinoid receptor agonists
AU5049699A (en) Phenylindole derivatives as 5-HT2A receptor ligands
AU7349298A (en) Prostaglandin agonists
AU1462095A (en) Indole derivatives as 5-ht1 agonists
AU6014900A (en) Staurosporin derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU1379900A (en) Novel substituted phenyloxazolidone derivatives
AU5444499A (en) Benzoxazine derivatives
AU2575399A (en) Oxazole derivatives as serotonin-1a receptor agonists
AU3550697A (en) Aminocyclohexane derivatives as 5-ht receptor agonists
AU4493496A (en) Substituted 1,4-piperazine-heteroaryl derivatives as 5-ht1d receptor agonists
AU2095099A (en) Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
AU2001247227A1 (en) 2-thioether a2a receptor agonists
AU5759299A (en) Ethylamine derivatives
AU6994396A (en) Substituted indolylpropyl-piperazine derivatives as 5-ht1dalpha agonists
AU1100300A (en) Piperidyloxadiazoles as dopamine receptor antagonists
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU8552098A (en) Pyrazoloquinolinone derivatives as gaba alpha 5 receptor inverse agonists
AU6994600A (en) Substituted benzoxazoles
AU2640999A (en) 1-azaindolizine derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU5239899A (en) Amidophosphate derivatives
AU2894099A (en) Phenanthrofuran derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase